Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Should Watson Be Consulted for a Second Opinion?
37
Zitationen
1
Autoren
2019
Jahr
Abstract
This article discusses ethical responsibility and legal liability issues regarding use of IBM Watson<sup>™</sup> for clinical decision making. In a case, a patient presents with symptoms of leukemia. Benefits and limitations of using Watson or other intelligent clinical decision-making tools are considered, along with precautions that should be taken before consulting artificially intelligent systems. Guidance for health care professionals and organizations using artificially intelligent tools to diagnose and to develop treatment recommendations are also offered.
Ähnliche Arbeiten
Machine Learning in Medicine
2019 · 3.603 Zit.
Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care
2006 · 3.166 Zit.
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 · 2.963 Zit.
Studies in health technology and informatics
2008 · 2.903 Zit.
Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success
2005 · 2.681 Zit.